NEWS & UPDATES
Latest Developments: In Vitro 3D Aged Human Skin Model Launch
As Part of DeNova’s ongoing R&D to better cater to the personal care market’s rigorous demands, we are pleased to announce that our latest model is able to replicate the repeated exposure of the skin to UVA (Photoaging) which is suitable for studies related to DNA photodamage, redox reaction and reversal of the aging process.
Latest Developments: In Vitro 3D Aged Human Skin Model Launch
As Part of DeNova’s ongoing R&D to better cater to the personal care market’s rigorous demands, we are pleased to announce that our latest model is able to replicate the repeated exposure of the skin to UVA (Photoaging) which is suitable for studies related to DNA photodamage, redox reaction and reversal of the aging process.
Success Stories: Client Feature on IPI
Subsequent to signing a collaboration agreement between DeNova Sciences and JAH Tech in 2019, we are proud of our Client to be recognized by the Intellectual Property Intermediary (a subsidiary of Enterprise Singapore established under Singapore’s Ministry of Trade and Industry) in October 2020.
Success Stories: Client Feature on IPI
Subsequent to signing a collaboration agreement between DeNova Sciences and JAH Tech in 2019, we are proud of our Client to be recognized by the Intellectual Property Intermediary (a subsidiary of Enterprise Singapore established under Singapore’s Ministry of Trade and Industry) in October 2020.
Webinar: Shaping Your Science Beyond Science (16 Oct 2020)
In conjunction with our listing as a partner on the Technology Platform of A*star Research Support Centre (RSC), we are co-organising this webinar to introduce our capabilities, overcoming commercialisation barriers and an anecdote of our client’s commercialisation journey.
Register now to find out more!
Webinar: Shaping Your Science Beyond Science (16 Oct 2020)
In conjunction with our listing as a partner on the Technology Platform of A*star Research Support Centre (RSC), we are co-organising this webinar to introduce our capabilities, overcoming commercialisation barriers and an anecdote of our client’s commercialisation journey.
Register now to find out more!
Technological Advancement (reported by Reuters)
Denova Sciences is proud to be part of a research collaboration with Nanyang Technological University (School of Mechanical & Aerospace Engineering) to work on 3D bio-printing of skin, funded by NAMIC.
Technological Advancement
Denova Sciences is proud to be part of a research collaboration with Nanyang Technological University (School of Mechanical & Aerospace Engineering) to work on 3D bio-printing of skin, funded by NAMIC.
SCSS Symposium “Science Behind the Global Players” & 15 Years Anniversary
Denova Sciences is excited to be involved in this rare opportunity to hear keynote speakers from three key beauty industry leaders (Johnson & Johnson, Shiseido and Procter & Gamble), as they come together to share the Science and/or technology that is essential for the transformation of their products or application to be competitive and flourish in the competitive commercial spaces.
SCSS Symposium “Science Behind the Global Players” & 15 Years Anniversary
Denova Sciences is excited to be involved in this rare opportunity to hear keynote speakers from three key beauty industry leaders (Johnson & Johnson, Shiseido and Procter & Gamble), as they come together to share the Science and/or technology that is essential for the transformation of their products or application to be competitive and flourish in the competitive commercial spaces.
Strategic Collaboration (Taiwan, Republic of China)
Denova Sciences is proud to announce the signing of a MOU with Maria Von Stem Cell and Biotechnology Company (瑪旺幹細胞醫學生物科技). Together, we are targeting the R&D driven personal care and pharmaceutical markets by offering an ethical non-animal testing approach for companies keen to develop the use of Chinese derived Asian human cell and skin equivalents.
Strategic Collaboration
Devova Sciences is proud to announce the signing of a MOU with Maria Von Stem Cell and Biotechnology Company (瑪旺幹細胞醫學生物科技). Together, we are targeting the R&D driven personal care and pharmaceutical markets by offering an ethical non-animal testing approach for companies keen to develop the use of Chinese derived Asian human cell and skin equivalents.